RAB3IP, RAB3A interacting protein, 117177

N. diseases: 6; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.020 AlteredExpression disease BEFREE Overexpression of Rab3IP in gastric cancer was verified at both transcriptional and translational levels. 30005870 2018
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.020 AlteredExpression disease BEFREE <b>Results:</b> Overexpression of Rab3IP in GC samples enhanced the cell proliferation ability, but decreased the number of autophagosomes and expression of LC3-II and sequestosome-1 (SQSTM1 or p62) markers. 30519341 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.020 AlteredExpression disease BEFREE Overexpression of Rab3IP in gastric cancer was verified at both transcriptional and translational levels. 30005870 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.020 AlteredExpression disease BEFREE <b>Results:</b> Overexpression of Rab3IP in GC samples enhanced the cell proliferation ability, but decreased the number of autophagosomes and expression of LC3-II and sequestosome-1 (SQSTM1 or p62) markers. 30519341 2018
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.010 Biomarker disease BEFREE Our study confirmed that HOTAIR promotes PD progression by regulating miR-126-5p and RAB3IP in a ceRNA-dependent manner and further clarified how HOTAIR works in PD. 30738012 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.010 Biomarker phenotype BEFREE RAB3A interacting protein (Rab3IP) has been determined to be involved in cancer progression; however, its expression pattern and function in gastric cancer remain unknown. 30005870 2018
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.010 AlteredExpression phenotype BEFREE Rab3IP (knockdown and overexpression) and light chain 3 (LC3) lentiviruses were transfected into GC cells, and cell proliferation was measured using cell counting kit-8, plate clone formation, flow cytometry, and tumorigenesis assays. 30519341 2018
CUI: C1301194
Disease: Salivary duct carcinoma
Salivary duct carcinoma
0.010 Biomarker disease BEFREE Tumor-specific amplicons were identified at 11q23.3 (PVRL1) in ACC, 11q13.3 (NUMA1) in MEC, and 6p21.1 (CCND3), 9p13.2 (PAX5), 12q15 (CNOT2/RAB3IP), 12q21.1 (GLIPR1L1), and 17q12 (ERBB2/CCL4) in SDC. 23583282 2013